CorMedix Inc. (CRMD) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 7.83 at 4:15 pm ET, low 7.65 at 12:00 pm ET.
the bull case· 3
+3.06%
increase in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26195
managers reporting a position in the latest quarterly filings
13fJun 30 '263
of the funds on file reporting a position in CRMD
n-portas of Jun 30 '26the bear case· 3
5 of 21
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '260.02%
of iShares Russell two thousand ETF assets, the largest fund weight on file
n-portJun 30 '264 of 8
recent reports where the move came in under the options implied range
earnings historyimplied vs realizedSides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 9 '26 report. Not a forecast, not advice.
The one company CorMedix Inc. moves with most closely does not share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
194 managers report a position worth $359.8M between them, and 27 of them hold 80% of it.
tall tick = annual report · 1 on record
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
CorMedix Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
CRMD (CorMedix Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.